Goldman Sachs’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-16,776
| Closed | -$8K | – | 4807 |
|
|
2016
Q2 | $8K | Buy |
+16,776
| New | +$8K | ﹤0.01% | 4480 |
|
|
2016
Q1 | – | Sell |
-16,006
| Closed | -$49K | – | 4827 |
|
|
2015
Q4 | $49K | Buy |
16,006
+4,342
| +37% | +$13.3K | ﹤0.01% | 4190 |
|
|
2015
Q3 | $52K | Buy |
+11,664
| New | +$52K | ﹤0.01% | 4338 |
|
|
2015
Q2 | – | Sell |
-32,046
| Closed | -$287K | – | 4927 |
|
|
2015
Q1 | $287K | Buy |
32,046
+21,450
| +202% | +$192K | ﹤0.01% | 3675 |
|
|
2014
Q4 | $60K | Buy |
+10,596
| New | +$60K | ﹤0.01% | 4350 |
|